Our project is geared towards indigenously developing off-the-shelf allogenic CAR-NK and Gamma delta T based cell therapies for difficult-to-treat tumor with specific focus on Ovarian Cancer, Lung Cancer, Head & Neck cancers and Breast Cancer. Our focus has constantly been seamlessly improving our cell therapy product(s) & it’s formulation for it’s sustained activity at the tumor microenvironment.